JasonKeithSicklickMDFACS(He/Him)
General Surgery • La Jolla, CAHepatobiliary Surgery, Surgical Oncology (Other than Breast)
Professor of Surgery, UC San Diego School of Medicine
Dr. Sicklick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences Dr
La Jolla, CA 92093Phone+1 858-822-6173Fax+1 858-228-5153- Is this information wrong?
Summary
- Dr. Jason Sicklick is an NIH and FDA R01 funded investigator, Professor of Surgery, Executive Vice Chair of Research in the Department of Surgery, and Co-Leader of the Sarcoma Disease Team at the UC San Diego Moores Cancer Center. He is a board-certified general surgeon and surgical oncologist specializing in the treatment of complex retroperitoneal and abdominal sarcomas, including gastrointestinal stromal tumors (GIST), as well as hepatobiliary oncology. In 2016, Dr. Sicklick was named the GIST Clinician of the Year by the Life Raft GIST Support Group, the largest GIST patient advocacy group in the world. In 2018, Dr. Sicklick was selected as a James IV Association of Surgeons fellow. This highly prestigious international traveling fellowship is designed to promote communication and collaboration in the international surgical community. In 2018 he also received the RARE Champion of Hope in Medical Care & Treatment Award from the Global Genes-Allies in Rare Disease, the largest global non-profit advocacy organization for individuals and families fighting rare and genetic diseases. In 2019, he received the Excellence in Mentoring Award from the UC San Diego Health Systems International. In 2021, he received the Rare Impact Award from the National Organization for Rare Disorders (NORD®), which aims to provide support for individuals with rare diseases by advocating and funding research, education, and networking among service providers.
He received his medical degree from the UCLA School of Medicine, completed his general surgery residency at The Johns Hopkins Hospital where he was the Administrative Chief Resident, and completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center where he was the Chief Administrative Fellow. He joined the UC San Diego Division of Surgical Oncology at Moores Cancer Center in 2010.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2008 - 2010
Johns Hopkins UniversityResidency, Surgery, 2000 - 2008
David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
CA State Medical License 2010 - 2026
NY State Medical License 2008 - 2011- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013-2019
- Fellow American College of Surgeons
Clinical Trials
- LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis Start of enrollment: 2014 Jul 01
- Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers Start of enrollment: 2015 Feb 01
- Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) Start of enrollment: 2018 Sep 12
Roles: Contact, Principal Investigator, Sub-Investigator
Publications & Presentations
PubMed
- If it's a target, it's a pan-cancer target: Tissue is not the issue.Jacob J Adashek, Shumei Kato, Jason K Sicklick, Scott M Lippman, Razelle Kurzrock> ;Cancer Treatment Reviews. 2024 Apr 1
- KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.Mühlenberg, T., Falkenhorst, J., Schulz, T., Fletcher, B., Teuber, A., Krzeciesa, D., Klooster, I., Lundberg, M., Wilson, L., Lategahn, J., von Mehren, M., Grunewald, ...> ;Journal of Clinical Oncology. 2024 Feb 26
- Transforming the Future of Surgeon-Scientists.Ladner, D., Goldstein, A., Billiar, T., Cameron, A., Carpizo, D., Chu, D., Coopersmith, C., DeMatteo, R., Feng, S., Gallagher, K., Gillanders, W., Lal, B., Lipshutz, G...> ;Annals of Surgery. 2024 Feb 1
- Join now to see all
Journal Articles
- Advanced Basal Cell Cancer: Concise Review of Molecular Characteristics and Novel Targeted and Immune TherapeuticsJ K Sicklick, P R Cohen, Annals of Oncology
- Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal MesotheliomaSudeep Banerjee, Adam M Burgoyne, Joel Baumgartner, Amanda Kirane, Grace Y Lin, Jason Sicklick, Journal of gastrointestinal surgery
- Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma DatabaseJohn Phay, Lawrence A Shirley, Lauren M Postlewait, Carmen C Solorzano, Colleen M Kiernan, Ioannis Hatzaras, Natalie Seiser, Tracy S Wang, Ryan C Fields, Konstantinos ..., Annals of Surgical Oncology
- Join now to see all
Press Mentions
Study Suggests Relationship Between Stromal Tumors and MesotheliomaAugust 2nd, 2022
Ripretinib Continues to Demonstrate Benefit in Advanced GISTNovember 11th, 2021- At Initial Cancer Diagnosis, a Deeply Personalised AssessmentOctober 14th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
